Back to Point72 Asset Management, L.P. Point72 Asset Management, L.P.

BLTEBLTE
Showing 7 of 10 quarters

Position history for Point72 Asset Management, L.P.Point72 Asset Management, L.P.'s holdings in Belite Bio, Inc. ADR

Point72 Asset Management, L.P. holds 51,186 shares of BLTE (Belite Bio, Inc. ADR), worth $7.9M as of 2026-Q2. This is a new position. BLTE represents 0.0% of Point72 Asset Management, L.P.'s portfolio.

Current Value

$7.9M

Current Shares

51,186

Total Value Change

+$7.7M

Total Shares Change

+46,386

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
51,186
-
$7.9M0.0%$153.99
38
2026-Q1
Exited
0
-100.0%
$00.0%$167.88
0
2025-Q4
Increased
284,437
+9075.4%
$45.5M0.1%$160.82
47
2025-Q3
Increased
3,100
+138.5%
$229,4000.0%$73.00
37
2025-Q2
New
1,300
-
$75,0100.0%$59.04
29
2024-Q4
Exited
0
-100.0%
$00.0%$61.97
0
2024-Q3
Decreased
4,800
-34.4%
$225,0240.0%$46.55
0

Other major holders of BLTE: UBS Group AG, RTW INVESTMENTS, LP, MILLENNIUM MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used